Grundinformationen
- Standard-SMILES
N#CC1(c2ccc(Cl)cc2)CCC1- InChIKey
XQONXPWVIZZJIL-UHFFFAOYSA-N- Summenformel
- C11H10ClN
- Durchschnittliche Molmasse
- 191,65 g/mol
- Monoisotopische Masse
- 191,050177
Namen und Bezeichner
- Bevorzugter Name
- 1-(4-Chlorophenyl)cyclobutanecarbonitrile
- IUPAC
- 1-(4-chlorophenyl)cyclobutane-1-carbonitrile
- Lokaler Name
- 1-(4-Chlorphenyl)cyclobutancarbonitril
- Englischer Name
- 1-(4-Chlorophenyl)-1-cyclobutanecarbonitrile
- Summenformel
- C11H10ClN
- Molmasse
- 191.66
Namen und Synonyme
1-(4-Chlorophenyl)cyclobutanecarbonitrile28049-61-8EINECS 248-799-7NSC 154613DTXSID30182328RefChem:74464DTXCID40104819248-799-71-(4-Chlorophenyl)-1-cyclobutanecarbonitrile1-(4-chlorophenyl)cyclobutane-1-carbonitrile1-(4-Chlorophenyl)cyclobutane CarbonitrileMFCD00065239
Weitere Namen anzeigen
SIBU-1Sibutramine Impurity 34Sibutramine Impurity 131-(4-Chlorophenyl)cyclobutanecarbon1-CYANO-1-(4-CHLOROPHENYL)CYCLOBUTANE1-(4-chlorophenyl)cyclobutancarbonitrile
Cyclobutanecarbonitrile, 1-(4-chlorophenyl)-NSC-1546131-(4-Chlorophenyl)cyclobutanecarbonitrile; Sibutramine Hydrochloride Monohydrate Impurity F; Sibutramine Impurity FNSC154613CCBCSibutramine Impurity F1-(p-Chlorophenyl)cyclobutanecarbonitrile1-(4-Chlorophenyl)-cyclobutanecarbonitrile
Datenbank-Bezeichner
- CAS
28049-61-8- PubChem CID
- 98621
- DTXSID
DTXSID30182328- UNII
- 35U5QL7HSY
- EC Number
- 248-799-7
- Nikkaji
- J250.638F
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 3,1
- Polarare Oberfläche (TPSA)
- 23,8 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 1
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 13
- Formalladung
- 0
- Komplexität
- 228
Physikochemische Eigenschaften
- Siedepunkt
- 295 °C · 295 °C (lit.)
- Dichte
- 1.137 g/mL · 1.137 g/mL at 25 °C (lit.)
- Brechungsindex
- 20 · n20/D 1.548(lit.)
- Flammpunkt
- 230 °F · >230 °F
- storage temp.
- Sealed in dry,Room Temperature
- Löslichkeit
- Chloroform (Sparingly), Methanol (Slightly)
- Aggregatzustand
- Oil
- Farbe
- Clear Colourless to Pale Yellow
- InChI
- InChI=1S/C11H10ClN/c12-10-4-2-9(3-5-10)11(8-13)6-1-7-11/h2-5H,1,6-7H2
- InChIKey
- XQONXPWVIZZJIL-UHFFFAOYSA-N
- SMILES
- C1(C2=CC=C(Cl)C=C2)(C#N)CCC1
- CAS Datenbank
- 28049 · 28049-61-8(CAS DataBase Reference)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
This chemical does not meet GHS hazard criteria for 2.1% (1 of 47) of reports.
Warning
H302 (97.9%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P321, P330, P332+P317, P337+P317, P362+P364, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 47 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Hazard Classes and CategoriesAcute Tox. 4 (97.9%)
Sicherheitsdaten
- wgk
- 3
- ridadr
- UN3276
- hs_code
- 29269095
- risk_code
- 20/21/22-36/37/38
- hazard_code
- Xn
- safety_code
- 36-36/37/39-26
- hazard_class
- 6.1
- packing_group
- III
- Speicherklasse
- 10 - Combustible liquids
- Hazard Classifications
- Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 Oral
Chemie und Industrie
Anwendungen
Verwenden1-(4-Chlorophenyl)-1-cyclobutanecarbonitrile (1-(4-chlorophenyl)-1-cyanocyclobutane) can be used in the synthesis of pharmacologically active metabolites of the anti-obesity drug-sibutramine.
Anbieter50 Anbieter
上海康恩博医药科技有限公司17510465506 · [email protected]
阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
杭州鸿喜生物医药科技有限公司18989489206 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
上海腾准生物科技有限公司19821570922 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
普善实业(陕西)有限公司029-81310890 18165209495 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
广东百科试剂有限公司13532366769 13686183698 · [email protected]
上海迈瑞尔生化科技有限公司4006356688 18621169109 · [email protected]
阿法埃莎(中国)化学有限公司400-6106006 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
成都添福瑞生物科技有限公司18030648795 18030648795 · [email protected]
广东云星生物技术有限公司0751-18902340975/189023400307 18902340307 · [email protected]
广东方信生物科技有限公司0751-2838688 13376594225 · [email protected]
韶远科技(上海)有限公司021-50795510 4000665055 · [email protected]
上海泰坦科技股份有限公司400-6009262 15618770481 · [email protected]
上海隆盛化工有限公司58099637 13585536065 · [email protected]
医恩医疗系统研发(上海)有限公司021-58958002 18930822973 · [email protected]
天津诺康医药科技有限公司022-23989838 13810451150 · [email protected]
广州科瑞生物技术有限公司20-66003216 18666003216 · [email protected]
赛默飞世尔科技(中国)有限公司800-810-5118 · [email protected]
TCI AMERICA800-4238616 · [email protected]
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
TCI Europe320-37350700 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
Cato Research Chemicals Inc.020-81960175 · [email protected]
苏州爱玛特生物科技有限公司0512-56316828 4008675858 · [email protected]
泰州同新生物医药科技有限公司0523-86818997 18652728585 · [email protected]
HBCChem, Inc.+1-510-219-6317 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
武汉开诺医药科技有限公司18040571231/1402788087
湖南氩氡医药科技有限公司13764359345 · [email protected]
杭州杰恒化工有限公司0571-87396432 · [email protected]
常州翔龙医药科技有限公司18915873328 18915873328 · [email protected]
南京恰风和医药科技有限公司025-57018978 18251899859 · [email protected]
青岛海智微元生物科技有限公司18317699790 18317699790 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
兰州华浩生物医药科技有限责任公司18189674620 · [email protected]
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司021-61415566 800-8193336 · [email protected]
苏州市晨科生物科技有限公司18662408853 · [email protected]
上海鑫科泰生物科技有限公司18043446684 · [email protected]
北京禾兴源科技有限公司18511709189 · [email protected]
广东翁江化学试剂有限公司0751-2815987 13927875076 · [email protected]
西安美川生物科技有限公司029-89275612 +8618991951683 · [email protected]
河南誉康卓宁进出口有限公司13393721940 · [email protected]
上海珈得尔化学技术有限公司021-4007787-550 400-7787-550 · [email protected]
安阳鸿蒙新材料有限公司19588588067 · [email protected]
Zugehörige Reaktionen
53
Verknüpfte Notizen
Wird geladen…